2012 Lung Cancer Research Foundation Annual Grant Program
Anthony Faber, PhD
Massachusetts General Hospital/Harvard Medical School
Research Project:
Differences in PI3K pathway inhibitors in EGFR mutant non-small cell lung cancer
Summary:
This is a renewal of a grant to further explore a critical pathway required for the growth of lung cancer and how it is affected by currently available therapeutics. Understanding the mechanisms of action and resistance could lead to alternative approaches and avoid resistance to such agents.